{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T02:24:31Z","timestamp":1788229471787,"version":"build-2803163510"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>\n                      To evaluate if titration of sweep gas oxygen fraction (F\n                      <jats:sub>D<\/jats:sub>\n                      O\n                      <jats:sub>2<\/jats:sub>\n                      ) targeting post oxygenator conservative oxygen strategy might decrease organ dysfunction compared with a liberal extracorporeal oxygenation strategy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Pilot multicenter randomized controlled trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Four ICUs in three teaching hospitals of the eastern France.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>Cardiogenic shock supported by venoarterial extracorporeal membrane oxygenation (VA ECMO).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>\n                      F\n                      <jats:sub>D<\/jats:sub>\n                      O\n                      <jats:sub>2<\/jats:sub>\n                      titration targeting postoxygenator oxygen partial pressure (P\n                      <jats:sub>POST<\/jats:sub>\n                      O\n                      <jats:sub>2<\/jats:sub>\n                      ) 100\u2013150\u2009mm Hg in the conservative arm, and F\n                      <jats:sub>D<\/jats:sub>\n                      O\n                      <jats:sub>2<\/jats:sub>\n                      maintained at 100% in the liberal arm.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results:<\/jats:title>\n                    <jats:p>\n                      Primary outcome was mean plasmatic intestinal fatty acid binding protein (IFABP) level at day 2, a marker of gut damage. Secondary outcome were feasibility criteria, biomarkers of hepatic and renal dysfunction, biomarkers of inflammation and antioxidant system. Among the 55 patients analyzed, 29 were assigned to the conservative arm and 26 to the liberal arm. The two arms were well separated over the first 7 days: F\n                      <jats:sub>D<\/jats:sub>\n                      O\n                      <jats:sub>2<\/jats:sub>\n                      61 (\u00b1 7) % vs. 98 (\u00b1 5) %, and P\n                      <jats:sub>POST<\/jats:sub>\n                      O\n                      <jats:sub>2<\/jats:sub>\n                      139 (\u00b1 40) mm Hg vs. 420 (\u00b1 50) mm Hg, in the conservative and liberal arms, respectively. However, in the conservative arm, the mean proportion of time within the targeted window was only 33 (\u00b1 20) %. IFABP on day 2 did not differ between conservative and liberal arms (407 [206\u2014549] pg\/mL vs. 569 [247\u2014708] pg\/mL,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.25). Lactate, vasoactive inotropic score, aspartate aminotransferase, prothrombin time, serum creatinine, need for renal replacement therapy, tumor necrosis factor-\u03b1, IL-6 and IL-8 did not differ between the two arms at day 0, 2, and 6 after randomization.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      In patients supported by VA ECMO for cardiogenic shock, a conservative oxygen target strategy was not easily feasible, as P\n                      <jats:sub>POST<\/jats:sub>\n                      O\n                      <jats:sub>2<\/jats:sub>\n                      could be maintained within the targeted window only 33% of time. However, the conservative and liberal arms were well separated regarding P\n                      <jats:sub>POST<\/jats:sub>\n                      O\n                      <jats:sub>2<\/jats:sub>\n                      , and we did not find any difference in biomarkers of organ dysfunction.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000006882","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:00:07Z","timestamp":1758636007000},"page":"e2552-e2561","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Impact of Conservative Vs. Liberal Extracorporeal Oxygen Target During Venoarterial Extracorporeal Membrane Oxygenation Support for Cardiogenic Shock: A Pilot Randomized Control Trial"],"prefix":"10.1097","volume":"53","author":[{"given":"Hadrien","family":"Winiszewski","sequence":"first","affiliation":[{"name":"D\u00e9partement de r\u00e9animation m\u00e9dicale, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Puyraveau","sequence":"additional","affiliation":[{"name":"Methodology and Statistics Unit, University Hospital, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Kimmoun","sequence":"additional","affiliation":[{"name":"D\u00e9partement de m\u00e9decine intensive r\u00e9animation, CHU Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gael","family":"Piton","sequence":"additional","affiliation":[{"name":"D\u00e9partement de r\u00e9animation m\u00e9dicale, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karena Moretto","family":"Riedweg","sequence":"additional","affiliation":[{"name":"Laboratoire de biochimie m\u00e9dicale, CHU Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Moltenis","sequence":"additional","affiliation":[{"name":"Vigilance Unit, Department of Clinical Research and Innovation, University Hospital of Besan\u00e7on, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Andr\u00e9","family":"Pinel","sequence":"additional","affiliation":[{"name":"D\u00e9partement de r\u00e9animation m\u00e9dicale, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Besch","sequence":"additional","affiliation":[{"name":"D\u00e9partement d\u2019Anesth\u00e9sie R\u00e9animation Chirurgicale, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Gr\u00e9goire","family":"Guinot","sequence":"additional","affiliation":[{"name":"D\u00e9partement d\u2019anesth\u00e9sie-r\u00e9animation chirurgicale, CHU Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Capellier","sequence":"additional","affiliation":[{"name":"D\u00e9partement de r\u00e9animation m\u00e9dicale, Besan\u00e7on, France"},{"name":"Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Clayton, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"R1-20251204","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","article-title":"Extracorporeal life support in infarct-related cardiogenic shock.","volume":"389","author":"Thiele","year":"2023","journal-title":"N Engl J Med"},{"key":"R2-20251204","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.122.062949","article-title":"Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: Results of the ECMO-CS randomized clinical trial.","volume":"147","author":"Ostadal","year":"2023","journal-title":"Circulation"},{"key":"R3-20251204","first-page":"e010328","article-title":"Exposure to arterial hyperoxia during extracorporeal membrane oxygenator support and mortality in patients with cardiogenic shock.","volume":"16","author":"Jentzer","year":"2023","journal-title":"Circ Heart Fail"},{"key":"R4-20251204","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.healun.2022.01.007","article-title":"Subclavian versus femoral arterial cannulations during extracorporeal membrane oxygenation: A propensity-matched comparison.","volume":"41","author":"Moussa","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"R5-20251204","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13613-024-01286-2","article-title":"Oxygenation management during veno-arterial ECMO support for cardiogenic shock: A multicentric retrospective cohort study.","volume":"14","author":"Winiszewski","year":"2024","journal-title":"Ann Intensive Care"},{"key":"R6-20251204","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13054-022-04133-7","article-title":"Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: A bicenter retrospective propensity score-weighted analysis.","volume":"26","author":"Moussa","year":"2022","journal-title":"Crit Care"},{"key":"R7-20251204","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13054-022-04102-0","article-title":"Optimizing PO2 during peripheral veno-arterial ECMO: A narrative review.","volume":"26","author":"Winiszewski","year":"2022","journal-title":"Crit Care"},{"key":"R8-20251204","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13054-024-04848-9","article-title":"Impact of hyperoxia on the gut during critical illnesses.","volume":"28","author":"Dai","year":"2024","journal-title":"Crit Care"},{"key":"R9-20251204","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/MAT.0000000000001510","article-title":"ELSO interim guidelines for venoarterial extracorporeal membrane oxygenation in adult cardiac patients.","volume":"67","author":"Lorusso","year":"2021","journal-title":"ASAIO J"},{"key":"R10-20251204","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.3390\/jcm11092390","article-title":"Vasoactive inotropic score as a prognostic factor during (cardio-)respiratory ECMO.","volume":"11","author":"Sandrio","year":"2022","journal-title":"J Clin Med"},{"key":"R11-20251204","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1007\/s00134-024-07564-8","article-title":"Conservative or liberal oxygen targets in patients on venoarterial extracorporeal membrane oxygenation.","volume":"50","author":"Burrell","year":"2024","journal-title":"Intensive Care Med"},{"key":"R12-20251204","doi-asserted-by":"crossref","first-page":"102738","DOI":"10.1016\/j.cpcardiol.2024.102738","article-title":"Arterial hyperoxia and mortality in the cardiac intensive care unit.","volume":"49","author":"Jentzer","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"R13-20251204","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13054-023-04379-9","article-title":"Hyperoxemia after reperfusion in cardiac arrest patients: A potential dose-response association with 30-day survival.","volume":"27","author":"Awad","year":"2023","journal-title":"Crit Care"},{"key":"R14-20251204","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1161\/CIR.0000000000000909","article-title":"Prevention of complications in the cardiac intensive care unit: A scientific statement from the American Heart Association.","volume":"142","author":"Fordyce","year":"2020","journal-title":"Circulation"},{"key":"R15-20251204","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1002\/ejhf.3409","article-title":"Ventilation strategies in cardiogenic shock: Insights from the AltShock-2 registry.","volume":"26","author":"Sacco","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"R16-20251204","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00134-019-05761-4","article-title":"Hyperoxia during cardiopulmonary bypass does not decrease cardiovascular complications following cardiac surgery: The CARDIOX randomized clinical trial.","volume":"45","author":"Abou-Arab","year":"2019","journal-title":"Intensive Care Med"},{"key":"R17-20251204","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1097\/CCM.0000000000002750","article-title":"Hyperoxemia and veno-arterial extracorporeal membrane oxygenation: Do not forget the gut.","volume":"46","author":"Winiszewski","year":"2018","journal-title":"Crit Care Med"},{"key":"R18-20251204","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/CCM.0b013e31828c26b5","article-title":"Enterocyte damage in critically ill patients is associated with shock condition and 28-day mortality.","volume":"41","author":"Piton","year":"2013","journal-title":"Crit Care Med"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006882","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T16:01:27Z","timestamp":1764864087000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000006882","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]}}}